PACB News
Pacific Biosciences of California, Inc.
$2.09
-$0.15(-6.70%)
46
Overall
40
Value
58
Tech
42
Quality
Market Cap
$654.02M
Volume
10.67M
52W Range
$1.07 - $3.44
Target Price
$2.76
PACB news: the latest Pacific Biosciences of California, Inc. headlines, press releases and market updates, newest first.
Latest PACB News
- Pacific Biosciences Enters Agreement for At-the-Market Stock OfferingTipRanks Auto-Generated Newsdesk · Nov 10, 2026
- UBS Sticks to Its Hold Rating for Pacific Biosciences (PACB)TipRanks Auto-Generated Intelligence Newsdesk · Nov 9, 2026
- Analysts Offer Insights on Healthcare Companies: Pacific Biosciences (PACB), Seres Therapeutics (MCRB) and Relay Therapeutics (RLAY)TipRanks Newsroom · Nov 5, 2026
- PacBio Reports Third-Quarter Revenue Growth Amid Ongoing LossesTipRanks Auto-Generated Newsdesk · Nov 4, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PACB | $2.09 | -6.7% | 10.67M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Pacific Biosciences of California, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW